Efficacy of Leuprorelin 3-Month Depot (11.25 mg) Compared to 1-Month Depot (3.75 mg) for Central Precocious Puberty in Chinese Girls: A Prospective Cohort Study
Table 2
The serum LH, FSH and E2 levels after leuprorelin acetate injection.
Group
LH (mIU/mL)
∆LH (mIU/mL)
FSH (mIU/mL)
∆FSH (mIU/mL)
E2 (pg/mL)
∆E2 (pg/mL)
Baseline
6-mon
value
Baseline
6-mon
value
Baseline
6-mon
value
LA3-mon
2.11 ± 1.83
0.37 ± 0.39
0.002
1.89 ± 1.79
4.11 ± 1.31
1.15 ± 0.66
0.001
3.12 ± 1.34
24.44 ± 11.84
2.50 ± 1.00
0.001
20.95 ± 12.18
LA1-mon
2.82 ± 2.31
0.44 ± 0.76
0.001
1.84 ± 2.20
4.65 ± 1.68
1.01 ± 0.85
0.001
3.62 ± 2.08
29.39 ± 15.35
3.84 ± 3.77
0.001
24.97 ± 11.98
t
1.381
0.309
−0.079
1.437
0.262
0.819
1.284
1.317
0.840
value
0.172
0.758
0.938
0.155
0.592
0.418
0.205
0.194
0.408
Data are presented as mean ± standard deviation. Abbreviations: LH, luteinizing hormone; FSH, follicle-stimulating hormone; E2, estradiol; LA, leuprorelin acetate.
